Safety of inhaled glycopyrronium in patients with COPD: a comprehensive analysis of clinical studies and post-marketing data
D'Urzo, Anthony D × Kerwin, Edward M Chapman, Kenneth R Decramer, Marc DiGiovanni, Robert D'Andrea, Peter Hu, Huilin Goyal, Pankaj Altman, Pablo #
DOVE Medical Press
International Journal of Chronic Obstructive Pulmonary Disease vol:10 pages:1599-1612
Chronic use of inhaled anticholinergics by patients with chronic obstructive pulmonary disease (COPD) has raised long-term safety concerns, particularly cardiovascular. Glycopyrronium is a once-daily anticholinergic with greater receptor selectivity than previously available agents.